Pathway Genomics Corp.

Pathway Genomics Corp.

Pathway Genomics Corp.

Overview
Date Founded

2008

Headquarters

4755 Nexus Center Drive,San Diego, CA 92121

Type of Company

Private

Employees (Worldwide)

101 - 250

Industries

Medical Support Services
Hospitals & Patient Services
Biotechnology
Other Business & Consulting Services
Holding Companies

Company Description

Pathway Genomics Corp. provides genetic testing services. Its testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. The firm provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. The company was founded in September 2008 by James Plante and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at Pathway Genomics Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Chief Financial Officer

General Counsel

Executive Vice President, Domestic Sales

Chief Scientific Officer

Chief Innovation Officer

Chief Business Officer

Chief Medical Officer

Director, BioInformatics

Laboratory Medical Director

Board of Directors

Executive Vice President & Chief Financial Officer at KBR, Inc.

Lifetime Member of the Board of Directors at The Atlantic Council of the United States

Former Professional at PepsiCo, Inc.

Operating Partner at HighBar Management LLC

Founder at Pathway Genomics Corp.

Paths to Pathway Genomics Corp.
Potential Connections via
Relationship Science
You
Pathway Genomics Corp.
Advisors & Consultants
Legal Advisor

Former Founding Partner at Cooley LLP

Advisor

Advisor at Evonexus

Political Donations
$3,900
2009
Investors
Details Hidden

The International Business Machines Corporation (IBM) is an American multinational technology and consulting corporation, with headquarters in Armonk, New York, United States. IBM manufactures and markets computer hardware and software, and offers infrastructure, hosting and consulting services in areas ranging from mainframe computers to nanotechnology.

Details Hidden

Edelson Technology Partners invests in technology-based ventures including start-ups, later-stage and mezzanine financings. The firm is interested in almost all areas of technology. Initial investments range from $500,000 to $1.5 million. The form of investment is usually convertible preferred stock, but may also be convertible debt or common stock. Investments are made in privately-held firms or in emerging public companies through private placements. The firm invests around the world including the US, Asia, Europe and Canada.Edelson seeks projects that offer proven management with entrepreneurial spirit, a sound financial plan, innovative technology, a proprietary advantage, a high quality product or service, a large market opportunity with the potential of at least $100 million in revenues, investment liquidity in five to seven years and a financial return of at least five-fold.

Details Hidden

Founders Fund Management focuses on seed and early-stage investments in high-growth companies within the technology sector. The firm is particularly interested in emerging consumer Internet companies. Investments typically range from $500,000 to $5 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pathway Genomics Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pathway Genomics Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Pathway Genomics Corp..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://news.relsci.com/organization/pathway-genomics-corp-1075736
  • https://news.relsci.com/organization/pathway-genomics-corp-1075736